임상 영양 시장 : 제품별, 투여 경로별, 용도별, 최종사용자별, 지역별(2025-2033년)

The global clinical nutrition market size reached USD 55.8 Billion in 2024. Looking forward, the market is expected to reach USD 104.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.2% during 2025-2033. There are various factors that are driving the market, which include increasing prevalence of chronic diseases and aging population worldwide, rising awareness about the importance of nutrition in healthcare, various technological advancements in personalized nutrition and medical nutrition, and changing dietary patterns and lifestyle habits.

Clinical nutrition refers to a specialized field of nutrition science that focuses on disease management by adopting medical nutrition therapies. It also includes the diagnosis and prevention of nutritional and metabolic conditions associated with chronic disorders that occur due to the lack of essential nutrients. Some of the commonly available types of clinical nutrition include infant nutrition, enteral nutrition, and parenteral nutrition. Clinical nutrition offers numerous benefits in reducing the consequences of malnutrition, enhancing the response to disease treatment, boosting immunity levels, enhancing ingestion abilities, etc.

Clinical Nutrition Market Trends:

The rising prevalence of metabolic disorders that increase the risk of obesity, high blood pressure, abnormal cholesterol levels, etc., is primarily driving the global clinical nutrition market. Moreover, the expanding geriatric population, who are more prone to chronic gastrointestinal ailments, is also propelling the demand for clinical nutrition in the home healthcare model. Besides this, elevating number of preterm births coupled with the inflating need for clinical nutrition in the pediatric medicine segment is further augmenting the market growth. Additionally, continuous upgradation of healthcare infrastructures and the introduction of government awareness programs regarding the easy accessibility to clinical nutrition procedures for disease management are acting as significant growth-inducing factors. Apart from this, in the COVID-19 pandemic, the demand for immunity-boosting alternatives, including clinical nutrition, has significantly increased to prevent the risk of coronavirus infection. The infection results in severe lack of appetite, anosmia dysgeusia, diarrhea, etc., which can lead to disease-related malnutrition. Clinical nutrition aid in treating acute malnutrition and protein deficiency along with improving immune defenses in COVID-19 patients. Moreover, significant innovations in clinical nutrition solutions, including lipid emulsions optimization, and the introduction of oral clinical nutrition formula in liquid form, are expected to drive the global clinical nutrition market over the forecasted period.

Key Market Segmentation:

Breakup by Product:

• Infant Nutrition
• Parental Nutrition
• Enteral Nutrition

Breakup by Route of Administration:

• Oral
• Enteral
• Parenteral

Breakup by Application:

• Cancer
• Malnutrition
• Metabolic Disorders
• Gastrointestinal Disorders
• Neurological Disorders
• Others

Breakup by End User:

• Pediatric
• Adults
• Geriatric

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, BASF SE, Baxter International Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols S.A., Koninklijke DSM N.V., Meiji Holdings Co. Ltd., Nestle S.A., Perrigo Company plc and Reckitt Benckiser Group PLC.

Key Questions Answered in This Report

• 1.What was the size of the global clinical nutrition market in 2024?
• 2.What is the expected growth rate of the global clinical nutrition market during 2025-2033?
• 3.What are the key factors driving the global clinical nutrition market?
• 4.What has been the impact of COVID-19 on the global clinical nutrition market?
• 5.What is the breakup of the global clinical nutrition market based on the product?
• 6.What is the breakup of the global clinical nutrition market based on the route of administration?
• 7.What is the breakup of the global clinical nutrition market based on the end user?
• 8.What are the key regions in the global clinical nutrition market?
• 9.Who are the key players/companies in the global clinical nutrition market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Clinical Nutrition Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Infant Nutrition
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Parental Nutrition
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Enteral Nutrition
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Route of Administration

• 7.1 Oral
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Enteral
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Parenteral
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Application

• 8.1 Cancer
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Malnutrition
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Metabolic Disorders
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Gastrointestinal Disorders
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Neurological Disorders
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Others
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast

9 Market Breakup by End User

• 9.1 Pediatric
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Adults
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Geriatric
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Abbott Laboratories
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 B. Braun Melsungen AG
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 SWOT Analysis
  • 15.3.3 BASF SE
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 Baxter International Inc.
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Danone S.A.
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 Fresenius SE & Co. KGaA
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 Grifols S.A.
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 Koninklijke DSM N.V.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Meiji Holdings Co. Ltd.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Nestle S.A.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
    • 15.3.10.4 SWOT Analysis
  • 15.3.11 Perrigo Company plc
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
    • 15.3.11.4 SWOT Analysis
  • 15.3.12 Reckitt Benckiser Group PLC
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio
    • 15.3.12.3 Financials
    • 15.3.12.4 SWOT Analysis